Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients

Combination Therapy With Sorafenib and Radiofrequency Ablation for Hepatocellular Carcinoma: A Glimmer of Light after the Storm Trial?

(2015) Antonio Facciorusso et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis

(2015) Annalisa Berzigotti et al.   HEPATOLOGY

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0–B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study

(2014) Xiaobin Feng et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation

(2014) Antonio Facciorusso et al.   DIGESTIVE AND LIVER DISEASE

Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation

(2014) Antonio Facciorusso et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Effects of Angiotensin II Type 2 Receptor Overexpression on the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo

(2014) Hongyan Du et al.   PLoS One

Postoperative therapy options for hepatocellular carcinoma

(2014) Jian-Hong Zhong et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma

(2013) Yao-Chun Hsu et al.   HEPATOLOGY

Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study

(2013) Gitte Vrelits Sørensen et al.   JOURNAL OF CLINICAL ONCOLOGY

Telmisartan Inhibits Cell Proliferation by Blocking Nuclear Translocation of ProHB-EGF C-Terminal Fragment in Colon Cancer Cells

(2013) Keiji Ozeki et al.   PLoS One

Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence

(2013) Zhong-Ming Tan   WORLD JOURNAL OF GASTROENTEROLOGY

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

(2012) Vincenzo Mazzaferro et al.   HEPATOLOGY

Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis

(2012) Yosui Tamaki et al.   JOURNAL OF GASTROENTEROLOGY

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Hepatocellular Carcinoma

(2011) Hashem B. El-Serag   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of metabolic factors on the prognosis of patients undergoing resection of hepatocellular carcinoma

(2010) Masaki Kaibori et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

(2010) Ilke Sipahi et al.   LANCET ONCOLOGY

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis

(2009) Gisèle N'Kontchou et al.   HEPATOLOGY

Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma

(2009) Hitoshi Yoshiji et al.   JOURNAL OF HEPATOLOGY

The renin-angiotensin system and malignancy

(2008) E. I. Ager et al.   CARCINOGENESIS

Analysis of Survival by Tumor Response and Other Comparisons of Time-to-Event by Outcome Variables

(2008) James R. Anderson et al.   JOURNAL OF CLINICAL ONCOLOGY